XML 16 R6.htm IDEA: XBRL DOCUMENT v3.23.2
Condensed Consolidated Statements of Stockholders’ Equity - USD ($)
$ in Thousands
Total
Rights Offering
Private Placement
Series A Preferred Stock
Common Stock
Common Stock
Rights Offering
Common Stock
Private Placement
Treasury Stock
Additional Paid-in Capital
Additional Paid-in Capital
Rights Offering
Additional Paid-in Capital
Private Placement
Accumulated Other Comprehensive Loss
Accumulated Deficit
Shares outstanding at beginning of period (in shares) at Dec. 31, 2021         42,296,121                
Stockholders' equity at beginning of period at Dec. 31, 2021 $ 422,491       $ 4     $ (4,445) $ 586,349     $ (3,725) $ (155,692)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Shares issued in connection with options exercise, net exercised (in shares)         342,661                
Shares issued in connection with options exercise, net exercised 1,369               1,369        
Shares issued in connection with employee stock plans (in shares)         2,475,511                
Shares issued pursuant to a license, services and collaboration agreement (in shares)         3,312                
Shares issued pursuant to a license, services and collaboration agreement 0               0        
Stock-based compensation expense and vesting of restricted stock units 6,539               6,539        
Other comprehensive income (loss) 7,510                     7,510  
Net income (loss) $ 5,543                       5,543
Shares outstanding at end of period (in shares) at Mar. 31, 2022 0       45,117,605                
Total stockholders' equity at end of period at Mar. 31, 2022 $ 443,452       $ 4     (4,445) 594,257     3,785 (150,149)
Shares outstanding at beginning of period (in shares) at Dec. 31, 2021         42,296,121                
Stockholders' equity at beginning of period at Dec. 31, 2021 422,491       $ 4     (4,445) 586,349     (3,725) (155,692)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Shares issued in connection with asset purchase 1,333                        
Other comprehensive income (loss) (14,719)                        
Net income (loss) $ (2,772)                        
Shares outstanding at end of period (in shares) at Jun. 30, 2022 25,000       45,621,763                
Total stockholders' equity at end of period at Jun. 30, 2022 $ 419,888       $ 4     (4,445) 601,237     (18,444) (158,464)
Shares outstanding at beginning of period (in shares) at Mar. 31, 2022 0       45,117,605                
Stockholders' equity at beginning of period at Mar. 31, 2022 $ 443,452       $ 4     (4,445) 594,257     3,785 (150,149)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Shares issued in connection with options exercise, net exercised (in shares)         10,370                
Shares issued in connection with options exercise, net exercised 80               80        
Shares issued in connection with employee stock plans (in shares)         16,320                
Shares issued pursuant to a license, services and collaboration agreement (in shares)         20,975                
Shares issued in connection with asset purchase (in shares)         103,570                
Shares issued in connection with asset purchase 1,333               1,333        
Shares issued in connection with preferred shares agreement (in shares)       25,000                  
Shares issued in connection with the settlement of the performance holdback contingent consideration relating to the acquisition of GlowUp (in shares)         352,923                
Shares issued in connection with the settlement of the performance holdback contingent consideration relating to the acquisition of GlowUp 260               260        
Stock-based compensation expense and vesting of restricted stock units 5,307               5,307        
Other comprehensive income (loss) (22,229)                     (22,229)  
Net income (loss) $ (8,315)                       (8,315)
Shares outstanding at end of period (in shares) at Jun. 30, 2022 25,000       45,621,763                
Total stockholders' equity at end of period at Jun. 30, 2022 $ 419,888       $ 4     (4,445) 601,237     (18,444) (158,464)
Shares outstanding at beginning of period (in shares) at Dec. 31, 2022       50,000 47,037,699                
Stockholders' equity at beginning of period at Dec. 31, 2022 155,252       $ 5     (4,445) 617,233     (24,145) (433,396)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Issuance of common stock (in shares)           19,561,050 6,357,341            
Issuance of common stock   $ 47,602 $ 13,890     $ 2       $ 47,600 $ 13,890    
Shares issued in connection with employee stock plans (in shares)         215,145                
Shares issued pursuant to a license, services and collaboration agreement (in shares)         3,312                
Stock-based compensation expense and vesting of restricted stock units 5,920               5,920        
Other comprehensive income (loss) (1,696)                     (1,696)  
Net income (loss) (37,680)                       (37,680)
Shares outstanding at end of period (in shares) at Mar. 31, 2023       50,000 73,174,547                
Total stockholders' equity at end of period at Mar. 31, 2023 183,288       $ 7     (4,445) 684,643     (25,841) (471,076)
Shares outstanding at beginning of period (in shares) at Dec. 31, 2022       50,000 47,037,699                
Stockholders' equity at beginning of period at Dec. 31, 2022 155,252       $ 5     (4,445) 617,233     (24,145) (433,396)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Shares issued in connection with asset purchase 0                        
Other comprehensive income (loss) (1,968)                        
Net income (loss) (171,563)                        
Shares outstanding at end of period (in shares) at Jun. 30, 2023       0 73,797,250                
Total stockholders' equity at end of period at Jun. 30, 2023 52,770       $ 7     (4,445) 688,280     (26,113) (604,959)
Shares outstanding at beginning of period (in shares) at Mar. 31, 2023       50,000 73,174,547                
Stockholders' equity at beginning of period at Mar. 31, 2023 183,288       $ 7     (4,445) 684,643     (25,841) (471,076)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Shares issued in connection with employee stock plans (in shares)         622,703                
Stock-based compensation expense and vesting of restricted stock units 3,637               3,637        
Elimination of mandatorily redeemable preferred shares (in shares)       (50,000)                  
Other comprehensive income (loss) (272)                     (272)  
Net income (loss) (133,883)                       (133,883)
Shares outstanding at end of period (in shares) at Jun. 30, 2023       0 73,797,250                
Total stockholders' equity at end of period at Jun. 30, 2023 $ 52,770       $ 7     $ (4,445) $ 688,280     $ (26,113) $ (604,959)